erythrocentaurin: isolated from Centaurium umbellatum Gilib, Enicostemma hyssopifolium & Swertia lawii; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Swertia | genus | A plant genus of the family GENTIANACEAE. It is a source of swertiapuniside and IRIDOID GLYCOSIDES.[MeSH] | Gentianaceae | A plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.[MeSH] |
| Centaurium | genus | A plant genus of the family GENTIANACEAE. Triterpene lactones and other compounds have been isolated from species of this genus. The common name of century plant has also been used for the AGAVE genus.[MeSH] | Gentianaceae | A plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 191120 |
| CHEMBL ID | 3397161 |
| SCHEMBL ID | 1649253 |
| MeSH ID | M0050921 |
| Synonym |
|---|
| 5-formyl-3,4-dihydroisocoumarin |
| erythrocentaurin |
| 50276-98-7 |
| 1-oxo-3,4-dihydroisochromene-5-carbaldehyde |
| unii-295rs6d94v |
| 295rs6d94v , |
| erythrocentaurin [mi] |
| erythrocentaurine |
| 1h-2-benzopyran-5-carboxaldehyde, 3,4-dihydro-1-oxo- |
| 3,4-dihydro-1-oxo-1h-2-benzopyran-5-carboxaldehyde |
| isocoumarin, 5-formyl-3,4-dihydro- |
| SCHEMBL1649253 |
| 1-oxo-3,4-dihydro-1h-isochromene-5-carbaldehyde # |
| TUADBWMDDLWUME-UHFFFAOYSA-N |
| CHEMBL3397161 |
| DTXSID30198282 |
| 5-formyl-2,3-dihydroisocoumarin |
| AKOS032949101 |
| 1-oxoisochroman-5-carbaldehyde |
| Q27254390 |
| 5-formyl-3,4-dihydroisocoumarin; 1-oxo-3,4-dihydroisochromene-5-carbaldehyde |
| 1-oxo-3,4-dihydro-1h-2-benzopyran-5-carbaldehyde |
| CS-0024353 |
| HY-N3861 |
Erythrocentaurin is a relatively simple natural product present among the members of Gentianaceae.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Erythrocentaurin is a relatively simple natural product present among the members of Gentianaceae. " | ( Rapid preparative isolation of erythrocentaurin from Enicostemma littorale by medium-pressure liquid chromatography, its estimation by high-pressure thin-layer chromatography, and its α-amylase inhibitory activity. Ahamad, J; Amin, S; Hassan, N; Mir, SR; Mujeeb, M, 2015) | 2.15 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1192284 | Inhibition of HBV HBsAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method | 2015 | Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7 | Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors. |
| AID1192286 | Inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells after 72 hrs by ELISA method | 2015 | Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7 | Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors. |
| AID1192283 | Cytotoxicity against human HepG2(2.2.15) cells after 72 hrs by MTT assay | 2015 | Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7 | Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors. |
| AID1192288 | Inhibition of HBV DNA replication in HepG2(2.2.15) cells exposed to fresh medium supplemented with compound every other day for additional 5 days by real-time PCR-fluorescent probing method | 2015 | Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7 | Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors. |
| AID1192285 | Selectivity index, ratio of CC50 for human HepG2(2.2.15) cells to IC50 for inhibition of HBV HBsAg secretion in HepG2(2.2.15) cells | 2015 | Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7 | Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors. |
| AID1192287 | Selectivity index, ratio of CC50 for human HepG2(2.2.15) cells to IC50 for inhibition of HBV HBeAg secretion in HepG2(2.2.15) cells | 2015 | Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7 | Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors. |
| AID1192289 | Selectivity index, ratio of CC50 for human HepG2(2.2.15) cells to IC50 for inhibition of HBV DNA replication in HepG2(2.2.15) cells | 2015 | Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7 | Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.21) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||